美股异动丨碧迪医疗盘前跌超3% Q4营收增长但下调财年销售预期

Group 1 - The core viewpoint of the news is that Becton Dickinson (BDX.US) experienced a pre-market decline of 3.25% following its fourth-quarter earnings report, which showed an 8.3% revenue growth to $5.9 billion, slightly below analyst expectations of $5.91 billion [1] - The company's unaudited annual revenue reached $21.8 billion, reflecting a year-over-year growth of approximately 8% [1] - Becton Dickinson has revised its sales guidance for fiscal year 2025 down from a range of $21.863 billion to $21.8 billion, indicating a more conservative outlook [1] Group 2 - The pre-market price for Becton Dickinson was reported at $180.70, down $6.07 or 3.25% from the previous close [2] - The closing price on October 15 was $186.77, with a trading volume of 1.1448 million shares [2] - The company's total market capitalization stands at $53.533 billion [2]